Michael E. Kamarck's Net Worth
$767 Thousand
Who is Michael E. Kamarck?
Michael E. Kamarck does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Trillium Therapeutics Inc., OMNI BIO PHARMACEUTICAL, INC., Vir Biotechnology, Inc., Passage BIO, Inc., WYETH, and Unilife Corp.
SEC CIK
Michael E. Kamarck's CIK is 0001450730
Past Insider Trading and Trends
2022 was Michael E. Kamarck's most active year for acquiring shares with 3 total transactions. Michael E. Kamarck's most active month to acquire stocks was the month of May. 2009 was Michael E. Kamarck's most active year for disposing of shares, totalling 12 transactions. Michael E. Kamarck's most active month to dispose stocks was the month of September. 2013 saw Michael E. Kamarck paying a total of $0.00 for 250,000 shares, this is the most they've acquired in one year. In 2009 Michael E. Kamarck cashed out on 247,433 shares for a total of $632,235.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vaxcyte, Inc. (PCVX) Snapshot price: $111.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +80.00% | 2.5K |
—
|
—
| 5.63K |
Jun 13
| |||
Form 4
|
∞
| 3.13K |
—
|
—
| 3.13K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trillium Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OMNI BIO PHARMACEUTICAL, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vir Biotechnology, Inc. (VIR) Snapshot price: $7.63
Chief Technology Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||